These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

951 related articles for article (PubMed ID: 31603055)

  • 1. Emerging Strategies in Stimuli-Responsive Nanocarriers as the Drug Delivery System for Enhanced Cancer Therapy.
    Saravanakumar K; Hu X; Ali DM; Wang MH
    Curr Pharm Des; 2019; 25(24):2609-2625. PubMed ID: 31603055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous and Exogenous Stimuli-Responsive Drug Delivery Systems for Programmed Site-Specific Release.
    Raza A; Rasheed T; Nabeel F; Hayat U; Bilal M; Iqbal HMN
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30901827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimuli-responsive Polymeric Nanosystems for Therapeutic Applications.
    Handa M; Singh A; Flora SJS; Shukla R
    Curr Pharm Des; 2022; 28(11):910-921. PubMed ID: 34879797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimuli-responsive polymeric micelles for drug delivery and cancer therapy.
    Zhou Q; Zhang L; Yang T; Wu H
    Int J Nanomedicine; 2018; 13():2921-2942. PubMed ID: 29849457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance.
    Ge Z; Liu S
    Chem Soc Rev; 2013 Sep; 42(17):7289-325. PubMed ID: 23549663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox-responsive nano-carriers as tumor-targeted drug delivery systems.
    Raza A; Hayat U; Rasheed T; Bilal M; Iqbal HMN
    Eur J Med Chem; 2018 Sep; 157():705-715. PubMed ID: 30138802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organ-restricted delivery through stimuli-responsive nanocarriers for lung cancer therapy.
    Dinakar YH; Karole A; Parvez S; Jain V; Mudavath SL
    Life Sci; 2022 Dec; 310():121133. PubMed ID: 36306866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound-Mediated Cancer Therapeutics Delivery using Micelles and Liposomes: A Review.
    Mukhopadhyay D; Sano C; AlSawaftah N; El-Awady R; Husseini GA; Paul V
    Recent Pat Anticancer Drug Discov; 2021; 16(4):498-520. PubMed ID: 34911412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics.
    Mi P
    Theranostics; 2020; 10(10):4557-4588. PubMed ID: 32292515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Progress in Stimuli-Responsive Intelligent Nano Scale Drug Delivery Systems: A Special Focus Towards pH-Sensitive Systems.
    Sethuraman V; Janakiraman K; Krishnaswami V; Kandasamy R
    Curr Drug Targets; 2021; 22(8):947-966. PubMed ID: 33511953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems.
    Karimi M; Ghasemi A; Sahandi Zangabad P; Rahighi R; Moosavi Basri SM; Mirshekari H; Amiri M; Shafaei Pishabad Z; Aslani A; Bozorgomid M; Ghosh D; Beyzavi A; Vaseghi A; Aref AR; Haghani L; Bahrami S; Hamblin MR
    Chem Soc Rev; 2016 Mar; 45(5):1457-501. PubMed ID: 26776487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Stimuli-Responsive Release Function Drug Delivery Systems for Tumor Treatment.
    Ding C; Tong L; Feng J; Fu J
    Molecules; 2016 Dec; 21(12):. PubMed ID: 27999414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smart Nanocarriers as an Emerging Platform for Cancer Therapy: A Review.
    Kenchegowda M; Rahamathulla M; Hani U; Begum MY; Guruswamy S; Osmani RAM; Gowrav MP; Alshehri S; Ghoneim MM; Alshlowi A; Gowda DV
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery.
    Cheng R; Meng F; Deng C; Klok HA; Zhong Z
    Biomaterials; 2013 May; 34(14):3647-57. PubMed ID: 23415642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies To Design and Synthesize Polymer-Based Stimuli-Responsive Drug-Delivery Nanosystems.
    Qin X; Li Y
    Chembiochem; 2020 May; 21(9):1236-1253. PubMed ID: 31889379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimuli-responsive nanoscale drug delivery systems for cancer therapy.
    Li L; Yang WW; Xu DG
    J Drug Target; 2019 Apr; 27(4):423-433. PubMed ID: 30173577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor.
    Yin Q; Shen J; Zhang Z; Yu H; Li Y
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1699-715. PubMed ID: 23611952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Light-Responsive and Dual-Targeting Liposomes: From Mechanisms to Targeting Strategies.
    Agiba AM; Arreola-Ramírez JL; Carbajal V; Segura-Medina P
    Molecules; 2024 Jan; 29(3):. PubMed ID: 38338380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.